Statistics of Visceral Sarcoma in Japan: Report From the Population‐Based National Cancer Registry (NCR) in Japan
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.27867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Shudai Muramatsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Tsukiji, Japan. Hauptthemen laut MEDLINE: Registries, Sarcoma, Viscera. Die Arbeit nennt 17 Literaturangaben. Gefördert von: This study was supported by National Cancer Center Research and Development Funds..
Abstract (Originalsprache)
Background and Objectives Sarcomas developing in the visceral organs are extremely rare, with no previous reports to describe their national epidemiology. We analyzed Japanese domestic statistics for visceral sarcoma, using the National Cancer Registry (NCR) in Japan, a population‐based database launched in 2016.
Methods
We identified 3245 cases of visceral sarcomas in the NCR dated 2016–2019 to analyze demographic and disease information, initial diagnostic process, volume and type of the hospitals, treatment, and prognosis.
Results
Visceral sarcoma shows a higher prevalence in the older generation (60+ years), with a significant male predominance ( p = 0.006). Leiomyosarcomas occurred frequently in the gastrointestinal tract ( N = 240; 39.5%), and angiosarcomas in the liver, gall bladder, pancreas, and spleen ( N = 244; 43.9%). Visceral sarcomas were often treated in facilities of lower volume without specific adjuvant treatments ( p < 0.001). The cumulative 3‐year overall survival was 44.8%, and several factors such as surgery or absence of chemotherapy positively affected survival.
Conclusions
This is the first nationwide study in Japan to analyze the inclusive epidemiology of visceral sarcomas. Visceral sarcomas are characterized by senior and male predominance with relatively poor prognosis, often managed in nonspecialized facilities and rarely with adjuvant therapies. Several histologic subtypes had the propensity to develop in specific organs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Tsukiji, Japan.
- Department of Orthopaedic Surgery, Kochi Medical School, Kochi, Nankoku, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Tsukiji, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Kashiwa, Japan.
- Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center Hospital, Tokyo, Tsukiji, Japan.
ORCID-Profile: Shudai Muramatsu, Shintaro Iwata
Förderung
- This study was supported by National Cancer Center Research and Development Funds.
Zitieren
APA
Muramatsu, S., Ogura, K., Morizane, C., Satake, T., Toda, Y., Iwata, S., Kobayashi, E., Higashi, T., Ikeuchi, M., & Kawai, A. (2025). Statistics of Visceral Sarcoma in Japan: Report From the Population‐Based National Cancer Registry (NCR) in Japan. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27867
Vancouver
Muramatsu S, Ogura K, Morizane C, Satake T, Toda Y, Iwata S, et al. Statistics of Visceral Sarcoma in Japan: Report From the Population‐Based National Cancer Registry (NCR) in Japan. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27867
BibTeX
@article{Muramatsu2025,
author = {Muramatsu, Shudai and Ogura, Koichi and Morizane, Chigusa and Satake, Tomoyuki and Toda, Yu and Iwata, Shintaro and Kobayashi, Eisuke and Higashi, Takahiro and Ikeuchi, Masahiko and Kawai, Akira},
title = {Statistics of Visceral Sarcoma in Japan: Report From the Population‐Based National Cancer Registry (NCR) in Japan},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.27867}
}
EUVIMED